AIM ImmunoTech to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14th
AIM ImmunoTech Inc. (NYSE American:AIM) will present at the H.C. Wainwright Annual Global Investment Conference from September 14-16, 2020. CEO Thomas K. Equels is set to deliver a presentation on September 14 at 5:00 p.m. ET, which will be available via live webcast. The company focuses on developing therapeutics for various cancers, immune disorders, and viral diseases, including COVID-19.
- None.
- None.
OCALA, FL / ACCESSWIRE / September 10, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) today announced that the company will be presenting at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020.
Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, is scheduled to present on Monday, September 14 at 5:00 p.m., Eastern Time. The presentation will be webcast live on the conference event platform, which can be accessed here.
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.
Contacts:
Crescendo Communications, LLC
Phone: 212-671-1021
Email: aim@crescendo-ir.com
AIM ImmunoTech Inc
Phone: 800-778-4042
Email: IR@aimimmuno.com
SOURCE: AIM ImmunoTech Inc.
View source version on accesswire.com:
https://www.accesswire.com/605463/AIM-ImmunoTech-to-Present-at-the-HC-Wainwright-22nd-Annual-Global-Investment-Conference-on-September-14th
FAQ
When is AIM ImmunoTech presenting at the H.C. Wainwright Annual Global Investment Conference?
Who is the CEO of AIM ImmunoTech presenting at the conference?
What is the focus of AIM ImmunoTech's research and development?
Where can I watch the AIM ImmunoTech presentation?
What dates is the H.C. Wainwright Annual Global Investment Conference being held?
